Related references
Note: Only part of the references are listed.Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis
Palak J. Trivedi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort
Zeinab Bakhshi et al.
JOURNAL OF GASTROENTEROLOGY (2020)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features
Carolina Palmela et al.
GUT AND LIVER (2018)
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismueller et al.
GASTROENTEROLOGY (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Surrogate Endpoints for Clinical Trials in Primary Sclerosing Cholangitis: Review and Results From an International PSC Study Group Consensus Process
Cyriel Y. Ponsioen et al.
HEPATOLOGY (2016)
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Reena Ravikumar et al.
JOURNAL OF HEPATOLOGY (2015)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Share Paper
